ERock, Inc. EROC

$8.90 -1.06% at last close

Analyst Consensus

Consensus Rating
Buy (7 Buy · 0 Hold · 0 Sell)
Average Price Target
$21.71
Implied Upside
+143.8%
Price Target Range
$16.00 – $28.00
Analysts (12 mo)
7

Recent Analyst Actions

DateFirmActionRatingPrice Target
2026-10-19
JP MorganMark Strouse
Maintains Overweight $21 → $18
2026-09-02
GuggenheimJoseph Osha
Maintains Buy $23 → $20
2026-08-17
Morgan StanleyAngel Castillo
Maintains Overweight $21 → $23
2026-07-17
B of A SecuritiesRoss Fowler
Upgrades Neutral → Buy $16
2026-07-06
BarclaysChristine Cho
Initiates coverage on Overweight $23
2026-07-06
GuggenheimJoseph Osha
Initiates coverage on Buy $23
2026-07-06
Wolfe ResearchSteve Fleishman
Initiates coverage on Outperform $24
2026-07-06
B of A SecuritiesRoss Fowler
Initiates coverage on Neutral $16
2026-07-06
Morgan StanleyAngel Castillo
Initiates coverage on Overweight $21
2026-07-06
JP MorganMark Strouse
Initiates coverage on Overweight $24
2026-07-06
Evercore ISI GroupNicholas Amicucci
Initiates coverage on Outperform $28
2014-04-24
UBS
Maintains Buy $8 → $7
2014-04-24
B of A Securities
Maintains Neutral $7 → $6
2014-02-28
Wells Fargo
Downgrades Outperform → Market perform —
2013-12-26
Raymond James
Upgrades Underperform → Market perform —
2013-12-24
Wells Fargo
Upgrades Market perform → —
2013-10-29
B of A Securities
Downgrades Buy → Neutral $9 → $8
2013-05-03
Raymond James
Downgrades Market perform → Underperform —
2013-01-03
B of A Securities
Maintains Buy $11 → $11
2012-12-14
Citigroup
Initiates coverage on Neutral $9
2012-08-24
B of A Securities
Initiates coverage on Buy $11
2012-08-07
Barclays
Maintains Equal-weight $12 → $10

Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.

Key Stats

Last Close
$8.90
Market Cap
$433.57 million
52-Week Range
$7.65 – $20.70
Average Volume
2.90 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.